SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 ...

TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in ...

TD Cowen downgraded SolarEdge (SEDG) to Hold from Buy with a price target of $16, down from $35. The firm cites deteriorating demand in Europe for the downgrade. This will delay a volume, margin ...

SolarEdge Technologies (SEDG – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Jeff Osborne from TD Cowen downgraded the rating on the stock to a ...

Bermuda-based specialty insurer AXIS Capital Holdings (NYSE:AXS) was initiated with a Buy rating and $118 price target at TD Cowen on improved underwriting, rising excess and surplus market and ...

Fintel reports that on October 4, 2024, TD Cowen upgraded their outlook for EVgo (NasdaqGS:EVGO) from Hold to Buy. As of September 25, 2024, the average one-year price target for EVgo is $5.66/share.

TD Cowen upgraded CVS Health (NYSE:CVS) to Buy from Hold and raised its price target to $85 from $59 on Friday, citing an attractive risk-reward setup following several updates related to its ...

Ulta Beauty Inc. was downgraded by TD Cowen Monday, with the analyst firm citing the increasing cost of competition for the specialty retailer. “While [Ulta] remains a category leader with a ...

On Monday , TD Cowen adjusted its outlook on monday.com Ltd. (NASDAQ:MNDY (NASDAQ:MNDY)), elevating the price target to $320 from $300 while maintaining a Buy rating on the stock. The firm's ...

Fintel reports that on October 4, 2024, TD Cowen upgraded their outlook for CVS Health (SNSE:CVSCL) from Hold to Buy. There are 3,178 funds or institutions reporting positions in CVS Health.

Investing.com -- Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.

TD Cowen has reiterated its Buy rating and $40.00 price target for Bath & Body Works Inc. (NYSE: NYSE:BBWI), highlighting the company's positioning amidst concerns over ocean freight impact.